V. Loué, M. Traoré, Charles Kacou, A. Kouame, Eléonore Gbary-Lagaud, Julie Grevoul-Fesquet
{"title":"Hyperthyroid Fetal Goiter: A Case Report","authors":"V. Loué, M. Traoré, Charles Kacou, A. Kouame, Eléonore Gbary-Lagaud, Julie Grevoul-Fesquet","doi":"10.11648/J.JGO.20190703.14","DOIUrl":null,"url":null,"abstract":"The persistent presence of maternal thyroid-stimulating hormone receptor antibody in patients with Graves’disease could cause fetal hyperthyroid goiter during pregnancy. The recognition and treatment of hyperthyroid fetal goiter are believed to be very important to optimize growth and intellectual development in affected fetuses. We report here, a case of a hyperthyroid fetal goiter identified by ultrasound exam at 27 weeks 5 days of gestation in a women having Graves’ disease and on antithyroid drugs therapy. This observation shows the fetal risk associated with the persistence of anti-TSH receptor antibodies in mothers with Graves' disease and the possibility of fetal approach.","PeriodicalId":77904,"journal":{"name":"Supplement to International journal of gynecology and obstetrics","volume":"3 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Supplement to International journal of gynecology and obstetrics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11648/J.JGO.20190703.14","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The persistent presence of maternal thyroid-stimulating hormone receptor antibody in patients with Graves’disease could cause fetal hyperthyroid goiter during pregnancy. The recognition and treatment of hyperthyroid fetal goiter are believed to be very important to optimize growth and intellectual development in affected fetuses. We report here, a case of a hyperthyroid fetal goiter identified by ultrasound exam at 27 weeks 5 days of gestation in a women having Graves’ disease and on antithyroid drugs therapy. This observation shows the fetal risk associated with the persistence of anti-TSH receptor antibodies in mothers with Graves' disease and the possibility of fetal approach.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
